Podcast 314: The Latest GLP-1 Research from WHOOP with Dr. Greg Grosicki

On this week’s episode, WHOOP Global Head of Human Performance and Principal Scientist Dr. Kristen Holmes sits down with Dr. Greg Grosicki, WHOOP Senior Research Scientist, to discuss all things GLP-1 and GLP-1 RAs.

Dr. Kristen Holmes and Dr. Greg Grosicki explore Greg’s career journey, his research background, exercise physiology, and how research at WHOOP aims to help people live longer, healthier lives. Greg discusses the WHOOP GLP-1 study, examining GLP-1 medications, their accessibility, and what users can expect from GLP-1 receptor agonists (GLP-1RAs). Together, Kristen and Greg break down the connections between GLP-1RAs, food addiction, Hollywood, and the concept of microdosing medications like Ozempic. The conversation highlights the significance of GLP-1 studies, the role of WHOOP in data collection, and the importance of recognizing research biases. They also discuss the relationship between GLP-1 and cardiovascular health, emphasizing the impact of exercise on heart health and strategies for preserving muscle tissue while using GLP-1RAs.

Episode Chapters

00:51 - GLP-1 research at WHOOP

1:32 - Greg’s journey to WHOOP and his research background

02:52 - Using exercise physiology to help people live longer and healthier

06:07 - How research at WHOOP can help people live better 

7:28 - Greg’s PhD study background

10:54 - WHOOP GLP-1 study

20:48 - GLP-1 medications and accessibility

23:09 - What should people expect from a GLP-1RA

24:30 - Food addiction

26:16 - Hollywood

27:10 - Microdosing Ozempic

28:20 - Why WHOOP is researching GLP-1s

32:56 - The results of the WHOOP GLP-1 study

35:55 - Addressing research bias

39:07 - GLP-1 and cardiovascular health

40:28 - The impact of exercise on cardiovascular health

43:42 - Maintaining muscle tissue when on GLP-1RAs